跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Nervagest
Approved
STANDARD
Nervagest
Samjin Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a23c9a427821d473
Company
Samjin Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
a23c9a427821d473
Drug Approval Philippines Name
Nervagest
Product Name
Nervagest
Registration Number
DR-XY44616
Brand Name
Nervagest
Generic Name
Pregabalin
Dosage Form
Capsule
Dosage Strength
75 mg
Manufacturer
Samjin Pharmaceutical Co., Ltd.
Importer
Natrapharm, Inc.
Distributor
Natrapharm, Inc.
Company Detail Path
/organization/samjin-pharmaceutical-co-ltd
Issuance Date
20 August 2024
Expiry Date
04 June 2030
Pharmacologic Category
Antiepileptic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a23c9a427821d473
Type
Standard
Back to Philippines FDA Approvals
Nervagest - Philippines FDA Drug Approval Details